Skip to main navigation Skip to search Skip to main content

Prognostic impact of baseline serum C-reactive protein in metastatic renal cell carcinoma treated with sunitinib.

  • Vano Yann-Alexandre
  • , Benoit Beuselinck
  • , Pascal Wolter
  • , Corine Teghom
  • , Debruyne Philip
  • , Alexandra Karadimou
  • , Evelyne Lerut
  • , Paridaens Robert
  • , Patrick Schöffski
  • , Stephane Oudard
  • Department of Medical Oncology, Georges Pompidou European Hospital, Assistance Publique - Hôpitaux de Paris, Paris-5 René Descartes University, Paris, France
  • Medical Oncology Department, Georges Pompidou European Hospital, Paris, France; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium; Hopital Europeen Georges Pompidou, Paris, France; CHU de Tours, Tours, France; Alexandra Peripheral General Hospital, Athens, Greece; AZ Groeninge Hospital, Kortrijk, Belgium; IRCCS Policlinico San Matteo, Medicina Interna ed Oncologia Medica, Pavia, Italy; CHU de Bordeaux, Bordeaux, France; Georges Pompidou European Hospital, Paris, France
  • HEGP, Oncology Department, Paris, France
  • Inserm U674 Génomique Fonctionnelle des Tumeurs Solides, Université Paris-5 René Descartes, Paris, France
  • Department of Pathology, University Hospitals Leuven, Leuven, Belgium
  • Department of General Medical Oncology and Laboratory for Experimental Oncology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven, Leuven, Belgium

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)425-425
JournalJournal of Clinical Oncology
Volume31
Issue number6_suppl
DOIs
Publication statusPublished - 20 Feb 2013
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Access to Document

Cite this